Biopurification of monoclonal antibody (mAb) through crystallisation

Therapeutics based on monoclonal antibody (mAb) represent one of the most advanced biopharmaceuticals, being able to treat a wide range of challenging diseases such as cancers and arthritis. As the scale of mAb production steadily increases with the demand for mAb-based therapeutics, the downstream...

Full description

Bibliographic Details
Published in:Separation and Purification Technology
Main Author: Chen W.; Li X.; Guo M.; Link F.J.; Ramli S.S.; Ouyang J.; Rosbottom I.; Heng J.Y.Y.
Format: Review
Language:English
Published: Elsevier B.V. 2021
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100440810&doi=10.1016%2fj.seppur.2021.118358&partnerID=40&md5=07688f1b6a62ce55e9b813911484b879

Similar Items